Biogen, Inc.

56
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062X1037
USD
181.98
1.8 (1.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
9,266.00
9,417.00
9,433.00
10,402.00
12,356.00
12,714.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
9,266.00
9,417.00
9,433.00
10,402.00
12,356.00
12,714.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
250.00
246.00
246.00
253.00
225.00
187.00
General and Administration Expenses
2,403.00
2,549.00
2,403.00
2,674.00
2,504.00
2,374.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
7,142.00
7,785.00
7,159.00
7,537.00
8,555.00
6,884.00
Operating Profit (PBDIT) excl Other Income
2,124.00
1,631.00
2,274.00
2,865.00
3,800.00
5,829.00
Other Income
101.00
129.00
2,570.00
-218.00
1,648.00
1,627.00
Operating Profit (PBDIT)
2,898.00
2,255.00
5,363.00
3,134.00
5,905.00
7,921.00
Interest
250.00
246.00
246.00
253.00
225.00
187.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
673.00
494.00
518.00
487.00
457.00
464.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,906.00
1,296.00
3,591.00
1,745.00
5,047.00
7,125.00
Provision for Tax
273.00
135.00
632.00
52.00
992.00
1,158.00
Profit After Tax
1,632.00
1,161.00
3,046.00
1,556.00
4,000.00
5,888.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
11.19
7.97
20.87
10.40
24.80
31.42
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -1.60% vs -0.17% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 30.22% vs -28.27% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 1.38% vs 0.12% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 40.57% vs -61.89% in Dec 2023

Compare Profit and Loss Results of Biogen, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
9,266.00
3,236.00
6,030.00
186.34%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
9,266.00
3,236.00
6,030.00
186.34%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
250.00
24.00
226.00
941.67%
General and Administration Expenses
2,403.00
1,174.00
1,229.00
104.68%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
7,142.00
7,181.00
-39.00
-0.54%
Operating Profit (PBDIT) excl Other Income
2,124.00
-3,945.00
6,069.00
153.84%
Other Income
101.00
362.00
-261.00
-72.10%
Operating Profit (PBDIT)
2,898.00
-3,394.00
6,292.00
185.39%
Interest
250.00
24.00
226.00
941.67%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
673.00
189.00
484.00
256.08%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,906.00
-3,607.00
5,513.00
152.84%
Provision for Tax
273.00
-46.00
319.00
693.48%
Profit After Tax
1,632.00
-3,561.00
5,193.00
145.83%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
11.1871
-9.2734
20.46
220.64%
Profit And Loss - Net Sales
Net Sales 9,266.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.60% vs -0.17% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,124.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 30.22% vs -28.27% in Dec 2023

Profit And Loss - Interest
Interest 250.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.38% vs 0.12% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 1,632.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.57% vs -61.89% in Dec 2023